SEC Form 4 · accession 0001479791-18-000014
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Feb 14, 2018
Accepted (ET)
Feb 16, 2018 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Feb 14, 2018 | S | 100 | $0.11 | D | 25,434,976 | D | |
| INVO Bioscience Common Stock | Feb 15, 2018 | S | 11,050 | $0.11 | D | 25,423,926 | D | |
| INVO Bioscience Common Stock | Feb 16, 2018 | S | 2,740 | $0.11 | D | 25,421,186 | D |
Table II — derivative securities
No Table II lines on this filing.